There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement
about screening for prostate cancer.
The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer
screening; cohort and cross-sectional studies of the psychological harms of false-positive
prostate-specific antigen test results; and evidence on the natural history of prostate-specific
antigen-detected prostate cancer to address previously identified gaps in the evidence
from the 2002 USPSTF recommendation.
Current evidence is insufficient to assess the balance of benefits and harms of screening
for prostate cancer in men younger than age 75 years (I statement). Do not screen
for prostate cancer in men age 75 years or older (Grade D recommendation).